Download PDF
Am J Perinatol 2000; Volume 17(Number 02): 069-072
DOI: 10.1055/s-2000-9271
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

PERSISTENT PULMONARY HYPERTENSION AFTER MATERNAL NAPROXEN INGESTION IN A TERM NEWBORN: A CASE REPORT

Ajay J. Talati1,2 , Mubadda A. Salim1 , Sheldon B. Korones1,2
  • 1Department of Pediatrics, The University of Tennessee, Memphis, Memphis, Tennessee
  • 2Department of Obstetrics & Gynecology, The University of Tennessee, Memphis, Memphis, Tennessee
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Also available at
    Permissions and Reprints

ABSTRACT

Constricting effect of indomethacin on the ductus arteriosus of the fetus is well known. The fetal effects of other nonsteroid anti-inflammatory drugs (NSAIDs) like naproxen are not well reported. We report here a case of a 3790-g term neonate who developed persistent pulmonary hypertension after birth with a closed ductus arteriosus. The mother admitted to taking naproxen sodium immediately prior to the birth of the infant. The course of illness was progressively better on conservative management. Like indomethacin, other NSAIDs can also cause premature closure of fetal ductus arteriosus, pulmonary hypertension, and life-threatening problems to the neonate. Patient education regarding over-the-counter pain medication during pregnancy should be emphasized.

KEYWORD

NSAID - ductus arteriosus - prenatal

REFERENCES

  • 1 Schoenfeld A, Bar Y, Merlob P, Ovadia Y. NSAIDs: maternal and fetal considerations.  Am J Reprod Immunol . 1992;  28 141-147
    PubMedSearch in Google Scholar
  • 2 Moise K J. Effect of advancing gestational age on the frequency of fetal ductal constriction in association with maternal indomethacin use.  Am J Obstet Gynecol . 1993;  168 1350-1353
    PubMedSearch in Google Scholar
  • 3 Kleinman C S. Abnormal fetal cardiovascular physiology. In: Polin RA and Fox WW, eds. Fetal and Neonatal Physiology, Vol 1. Philadelphia: WB Saunders Company 1992: 666-670
    Search in Google Scholar
  • 4 Wild L M, Nickerson P A, Morin III C F. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb.  Pediatr Res . 1989;  25 251-257
    PubMedSearch in Google Scholar
  • 5 Morin III C F. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb.  Pediatr Res . 1989;  25 245-250
    PubMedSearch in Google Scholar
  • 6 Murphy J D, Rabinovitch M, Goldstein J D, Reid L M. The structural basis of persistent pulmonary hypertension.  J Pediatr . 1981;  98 962-967
    PubMedSearch in Google Scholar
  • 7 Van den Veyver B I, Moise K J, Ou C N, Carpenter R J. The effect of gestational age and fetal indomethacin levels on the incidence of fetal ductus arteriosus.  Obstet Gynecol . 1993;  82 500-504
    PubMedSearch in Google Scholar
  • 8 Takahashi Y, Harada K, Ishida A, Tanaka T, Tsuda A, Takada G. Doppler echocardiographic findings of indomethacin-induced occlusion of the fetal ductus arteriosus.  Am J Perinatol . 1996;  13 15-18
    PubMedSearch in Google Scholar
  • 9 Saenger J S, Mayer C, D'angelo L J, Manci E A. Ductus-dependent fetal cardiac defects contraindicate indomethacin tocolysis.  J Perinatol . 1992;  XII 41-47
    PubMedSearch in Google Scholar
  • 10 Moise K J, Huhta J C, Sharif D S. Indomethacin in the treatment of premature labor. Effects on fetal ductus arteriosus.  N Engl J Med . 1988;  319 327-331
    CrossrefPubMedSearch in Google Scholar
  • 11 Levin D L, Fixler D E, Morriss F C, Tyson J. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors.  J Pediatr . 1978;  92 478-483
    PubMedSearch in Google Scholar
  • 12 Momma K, Takeuchi H. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs.  Prostaglandins . 1983;  26 631-6431
    CrossrefPubMedSearch in Google Scholar